iZafe Group AB (OSTO:IZAFE B) Beta: -0.1373 (As of Aug. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:IZAFE B iZafe Group AB OSTO:IZAFE B
39 GF Score
Price kr0.34
GF Value kr0.47
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is iZafe Group AB Beta?

iZafe Group AB OSTO:IZAFE B +1.51% 39 Beta is -0.1373 as of Aug. 01, 2026. GuruFocus rates OSTO:IZAFE B with a GF Score™ of 39/100 and a GF Value™ of kr0.47 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-08-01), iZafe Group AB's Beta is -0.1373.


iZafe Group AB  (OSTO:IZAFE B) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


iZafe Group AB Beta Related Terms


iZafe Group AB Beta Historical Data

* Premium members only.

The historical data trend for iZafe Group AB's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iZafe Group AB Beta Chart

iZafe Group AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

iZafe Group AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

OSTO:IZAFE B vs ISRG, BDX, MDLN: Beta Comparison

For the Medical Instruments & Supplies subindustry, iZafe Group AB's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iZafe Group AB Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iZafe Group AB's Beta distribution charts can be found below:

* The bar in red indicates where iZafe Group AB's Beta falls into.


OSTO:IZAFE B
39GF Score
iZafe Group AB OSTO:IZAFE B
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

iZafe Group AB Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of -0.1373 mean?
iZafe Group AB (OSTO:IZAFE B) has a Beta of -0.1373 as of Aug. 01, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for iZafe Group AB and its competitors.
Is iZafe Group AB's Beta too high?
iZafe Group AB's current Beta is -0.1373. Overall, iZafe Group AB has a GF Score™ of 39/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iZafe Group AB's Beta compare to ISRG and BDX?
iZafe Group AB's Beta of -0.1373 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for iZafe Group AB and its competitors. iZafe Group AB's current Beta is -0.1373. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iZafe Group AB stock overvalued right now?
Based on GuruFocus' analysis, iZafe Group AB (OSTO:IZAFE B) is currently considered Modestly Undervalued. The stock's GF Value™ is kr0.47, compared to a current price of kr0.34 — trading 28.3% below its estimated fair value. The current Beta is -0.1373. iZafe Group AB's overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For iZafe Group AB (OSTO:IZAFE B), the current Beta is -0.1373 as of Aug. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is iZafe Group AB (OSTO:IZAFE B) Overvalued in 2026?

Based on GuruFocus' analysis, iZafe Group AB stock appears to be undervalued. The current stock price of kr0.34 is trading 28.3% below its estimated GF Value™ of kr0.47. GuruFocus considers iZafe Group AB to be Modestly Undervalued.

Key valuation signals for OSTO:IZAFE B:

  • Beta: -0.1373
  • GF Value™: kr0.47 vs. price of kr0.34 (28.3% below fair value)
  • GF Score™: 39/100 with 2 warning signs

No single metric tells the full story. See the OSTO:IZAFE B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


iZafe Group AB Business Description

Other Exchanges M02:Germany
Address David Bagares Gata 3, Stockholm, SWE, 111 38
iZafe Group AB is a Developer of a digital medication dispensing system designed to enhance patient safety and reduce medication errors in home healthcare. The company offers a smart medication robot with automated dispensing and remote monitoring, enabling public and private healthcare providers in Sweden, the Nordics, and international markets, improved treatment adherence and reduced caregiver workload.
39GF Score

Get the complete analysis for OSTO:IZAFE B

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.34
Price
kr0.47
GF Value